Brendan Twohig Strong | Tenet Healthcare Corp. |
Ronald A. Rittenmeyer | Tenet Healthcare Corp. |
Daniel J. Cancelmi | Tenet Healthcare Corp. |
J. Eric Evans | Tenet Healthcare Corp. |
William H. Wilcox | United Surgical Partners International, Inc. |
Jason B. Cagle | United Surgical Partners International, Inc. |
Keith B. Pitts | Tenet Healthcare Corp. |
Stephen M. Mooney | Conifer Health Solutions |
Joshua Raskin | Nephron Research LLC |
Chris Rigg | Deutsche Bank Securities, Inc. |
A.J. Rice | Credit Suisse Securities (NYSE:USA) LLC |
Kevin Mark Fischbeck | Bank of America Merrill Lynch |
Sarah E. James | Piper Jaffray & Co. |
Stephen Tanal | Goldman Sachs & Co. LLC |
Ana A. Gupte | Leerink Partners LLC |
John W. Ransom | Raymond James & Associates, Inc. |
Gary P. Taylor | JPMorgan Securities LLC |
Frank Morgan | RBC Capital Markets LLC |
Good day, everyone, and welcome to the Q4 2017 Tenet Healthcare Earnings Conference Call. My name is Dana, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, the company will conduct a question-and-answer session. I would now like to turn the conference over to Brendan Strong, Tenet's Vice President of Investor Relations.